Cytokinetics CYTK
NASDAQ CYTK
$58.54 +2.36 (+4.20%)
As of: Nov 11, 2026 · 3:59 PM EST

Cytokinetics (CYTK) Net Preferred Shares Issued and Repurchased (2010 - 2013)

Updated

Cytokinetics' Net Preferred Shares Issued and Repurchased came in at $12.32 million for FY2012, up 32.0% from $9.33 million in FY2011.

Analysis

Cytokinetics (CYTK) Net Preferred Shares Issued and Repurchased (2010 - 2013) Analysis & Trends

  • Per Business Quant, earlier years put Net Preferred Shares Issued and Repurchased at $9.33 million in FY2011.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Pref. Shares Issued (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Cytokinetics 7.83 Bn 3.24 Bn 47.10 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2013 -154.82 Mn
Mar 31, 2013 154.82 Mn
Jun 30, 2012 -130.18 Mn
Mar 31, 2012 142.50 Mn
Jun 30, 2011 -123.84 Mn
Mar 31, 2011 133.17 Mn
Mar 31, 2010 133.17 Mn
API Access

Cytokinetics Net Preferred Shares Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-preferred-shares-issued-and-repurchased&ticker=CYTK&period=max&api_key=YOUR_API_KEY